A Lifeline for Jewish Women With Ovarian Cancer

The genetic mutations that greatly increase a woman’s chance of getting breast cancer — mutations that are common among Ashkenazi Jewish women — also put her at high risk for ovarian cancer. So it makes sense that Sharsheret, which, since 2001, has been offering free support services to young Jewish women living with (or at high risk for) breast cancer, will be expanding to provide for women with ovarian cancer and those predisposed to the disease.

“We’ve found that women [with breast cancer] who are in our program, and women who are thinking about genetic testing, also have ovarian cancer on their minds,” Elana Silber, Sharsheret’s director of operations, told The Sisterhood.

Sharsheret is targeted at Jewish women in their 20s, 30s, and 40s. The organization offers confidential genetic counseling, peer support groups, health information, and seminars on topics such as parenting young children while undergoing cancer treatment. Within the next year, these services will made available to women suffering from or at risk for ovarian cancer, Silber said.

A Lifeline for Jewish Women With Ovarian Cancer

Your Comments

The Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. All readers can browse the comments, and all Forward subscribers can add to the conversation. In the interest of maintaining a civil forum, The Forward requires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not and will be deleted. Egregious commenters or repeat offenders will be banned from commenting. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and the Forward reserves the right to remove comments for any reason.

Recommend this article

A Lifeline for Jewish Women With Ovarian Cancer

Thank you!

This article has been sent!